Lindbrook Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.54K | Sell |
2,150
-168
| -7% | -$198 | ﹤0.01% | 2214 |
|
|
2024
Q4 | $4.24K | Buy |
2,318
+483
| +26% | +$884 | ﹤0.01% | 2057 |
|
|
2024
Q3 | $3.12K | Sell |
1,835
-797
| -30% | -$1.36K | ﹤0.01% | 2203 |
|
|
2024
Q2 | $3.61K | Buy |
2,632
+2,332
| +777% | +$3.2K | ﹤0.01% | 2137 |
|
|
2024
Q1 | $1.13K | Hold |
300
| – | – | ﹤0.01% | 2392 |
|
|
2023
Q4 | $2.94K | Hold |
300
| – | – | ﹤0.01% | 2125 |
|
|
2023
Q3 | $2.51K | Sell |
300
-34
| -10% | -$284 | ﹤0.01% | 2044 |
|
|
2023
Q2 | $4.44K | Buy |
334
+34
| +11% | +$452 | ﹤0.01% | 1863 |
|
|
2023
Q1 | $3.47K | Sell |
300
-132
| -31% | -$1.53K | ﹤0.01% | 2015 |
|
|
2022
Q4 | $3.53K | Buy |
432
+86
| +25% | +$704 | ﹤0.01% | 1981 |
|
|
2022
Q3 | $2K | Buy |
346
+300
| +652% | +$1.73K | ﹤0.01% | 2111 |
|
|
2022
Q2 | $0 | Sell |
46
-391
| -89% | – | ﹤0.01% | 2708 |
|
|
2022
Q1 | $4K | Buy |
437
+201
| +85% | +$1.84K | ﹤0.01% | 1729 |
|
|
2021
Q4 | $5K | Sell |
236
-82
| -26% | -$1.74K | ﹤0.01% | 1518 |
|
|
2021
Q3 | $8K | Sell |
318
-16
| -5% | -$403 | ﹤0.01% | 1091 |
|
|
2021
Q2 | $12K | Hold |
334
| – | – | ﹤0.01% | 983 |
|
|
2021
Q1 | $11K | Hold |
334
| – | – | ﹤0.01% | 985 |
|
|
2020
Q4 | $9K | Hold |
334
| – | – | ﹤0.01% | 961 |
|
|
2020
Q3 | $3K | Buy |
334
+331
| +11,033% | +$2.97K | ﹤0.01% | 1291 |
|
|
2020
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1855 |
|
|
2020
Q1 | – | Sell |
-298
| Closed | -$2K | – | 1827 |
|
|
2019
Q4 | $2K | Buy |
+298
| New | +$2K | ﹤0.01% | 1309 |
|